Main Line biopharm firm raises $49M
The company's lead product is being developed as a treatment of hypercholesterolemia, the medical term for having a high blood cholesterol level, and for the prevention of cardiovascular disease.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: John George Source Type: news